Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trialChao Gao, Ling Tao, Xingqiang He et al.|The Lancet|2024Cited by 142
Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and designChao Gao, Ling Tao, Xingqiang He et al.|BMC Cardiovascular Disorders|2024Cited by 11
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trialXiaoqiang Liu, Jinzhong Lin, Jun Dai et al.|Human Vaccines & Immunotherapeutics|2025Cited by 1